Insider · CIK 0001679841
John Donofrio Jr.
Files at AYTU (AYTU BIOPHARMA, INC). First filing -, latest -.
In brief
John Donofrio Jr. files SEC Form 4 as director at AYTU (AYTU BIOPHARMA, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Donofrio Jr. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 23,762 | Jul 30, 2026 |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 13,762 | Oct 7, 2025 |
| Nov 6, 2024 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Shares | +1,500 | $0.00 | $0 | 3,762 | Nov 8, 2024 |
Questions about John Donofrio Jr.
Answered from the filings on this page, as of the latest one.
Is John Donofrio Jr. buying or selling?
John Donofrio Jr. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Donofrio Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Donofrio Jr. has 0.
Where does John Donofrio Jr. file Form 4?
John Donofrio Jr. has filed Form 4 at AYTU (AYTU BIOPHARMA, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.